Clinical trials
Pediatric Cancer Patients clinical trials
Below are recruiting pediatric cancer patients clinical trials, each written for real people, not researchers. We’re tracking 172 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06858163Recruiting
Coping and attachment in pediatric cancer
This study looks at how parents and children cope with pediatric cancer. It involves questionnaires for both you and your child, and aims to understand how your relationship affects coping.
Monza, Monza-BrianzaAges 8–17 - NCT05658731Recruiting
Radiation planning study to protect thinking in children
This study compares how radiation is planned to see whether it better protects thinking and memory in children and young adults. It may help future patients by learning which planning approach leads to better cognitive (thinking) outcomes.
Washington D.C., District of ColumbiaAges 1–26 - NCT06033183Recruiting
Study of radiation sensitivity in children with cancer
This study looks at how children's bodies respond to radiation therapy for certain cancers. By analyzing blood samples, researchers hope to learn why some children experience more side effects, which could help personalize future treatments.
CaenAges 3–18 - NCT04897321RecruitingPhase 1
CAR T therapy for children with B7-H3 solid tumors
This early-phase study tests a lab-made immune therapy (CAR T cells) made from your own cells to treat children’s solid tumors that have a specific marker called B7-H3. It is designed for kids whose cancer has come back or did not respond to standard treatment, aiming to shrink tumors and keep the therapy safe.
Memphis, TennesseeAges Up to 21 years - NCT04222413RecruitingPhase 1
Study of metarrestin for advanced solid tumors
This study tests an experimental drug called metarrestin for people with solid tumors that have spread or come back after standard treatment. It may help by targeting a protein involved in cancer cell growth.
Fairway, KansasAges 12–120 - NCT02595255Recruiting
Testing a hormone marker to predict infertility risk after childhood cancer
This study looks at whether a blood test (a hormone marker) can predict a child’s future risk of infertility after cancer treatment. If it works, it could help families and doctors plan earlier fertility and puberty-related care.
Montegnée, LiègeAges 3–14 - NCT04765020RecruitingPhase 2/Phase 3
Fitness study for kids after cancer treatment
This study looks at how children and teens’ heart and fitness recover after cancer treatment. If you live in Krefeld and are at least 6 weeks past treatment, the study may offer a structured follow-up fitness assessment to see what helps recovery.
KrefeldAges 7–23 - NCT04678427Recruiting
Exercise program for kids and young adults in stem cell transplant
This trial tests whether a structured exercise program (“TEAM Me”) can improve movement and mobility during and after a blood stem cell transplant in young people with cancer. It may help reduce stiffness and weakness so you can move more comfortably during treatment.
Dallas, TexasAges 6–29 - NCT05372640RecruitingPhase 1
Drug combo trial for rare cancers with shared NUT features
This Phase 1 trial tests the safety and early signs of effectiveness of combining two anti-cancer drugs (ZEN003694 and abemaciclib) in teens and adults with metastatic or unresectable NUT carcinoma, breast cancer, and other solid tumors. It may help by finding a safer dose and whether the drug combination can shrink or control tumors that do not respond to standard treatments.
Los Angeles, CaliforniaAges 12 years+ - NCT05582551Recruiting
Screening test program for childhood cancer survivor senses
This trial helps improve how doctors check senses like hearing and vision after childhood cancer. It may help you (or your child) get better screening and support early for new or lasting side effects.
St Louis, MissouriAges 7–17 - NCT04477681Recruiting
Expanded access to cancer medicines for young people who need options
This trial helps children, teens, and young adults get an innovative cancer medicine when their disease has returned or hasn’t responded—and standard options are not available. It checks whether a “compassionate use” or off-label medicine plan can be carried out safely for the people who need it.
Villejuif, Val de MarneAges Up to 25 years - NCT05120518Recruiting
Donate a child’s tumor tissue for research after passing
This study collects a child’s tumor tissue and cells after death to help researchers learn more about cancers and other tumor conditions. You can take part if the required consent and permission are completed.
Chicago, IllinoisAges Any age - NCT07298096Recruiting
Vacuum thrombectomy for pulmonary embolism in cancer patients
This trial tests a computer-assisted vacuum device to remove blood clots from the lungs of people with cancer. It aims to see if this procedure is safe and improves quality of life for those with intermediate-risk pulmonary embolism.
Houston, TexasAges 18 years+ - NCT06423950Recruiting
Expert tumor board for hard-to-treat childhood cancers
This study brings together a team of experts to review your case and suggest personalized treatment options. It's for children and young adults with cancers that are hard to cure, even with standard treatments, to find new ways to treat them.
Tampa, FloridaAges Any age - NCT03988283RecruitingPhase 1
Personalized DNA vaccine for recurrent childhood brain tumors
This trial tests a personalized DNA vaccine made from your tumor’s DNA (neoantigens) to help your immune system fight the cancer. It is designed for children and young adults with certain recurrent or newly diagnosed brain/spine tumors, after they have had other standard treatments and tumor tissue is available for testing.
St Louis, MissouriAges Up to 25 years - NCT03816345RecruitingPhase 1
Nivolumab for advanced cancer with autoimmune conditions
This Phase 1 study tests nivolumab, an immunotherapy “anti-cancer accelerator,” in people with advanced cancer who also have an autoimmune disorder. It aims to see if nivolumab can be given safely and whether it may help shrink or control cancer.
Birmingham, AlabamaAges 18 years+ - NCT07217600RecruitingPhase 4
Preventing vomiting during kids' radiation therapy
This trial tests a new, easy-to-take film that melts on the tongue to prevent vomiting caused by radiation therapy in children with cancer. It may be a good option if your child is getting radiation to the belly or spine and has trouble swallowing pills.
Chongqing, Chongqing MunicipalityAges 1–14 - NCT07568509RecruitingEarly Phase 1
Oxytocin levels in children with pituitary disease
This study measures oxytocin (a natural hormone) levels in children who have pituitary gland problems. Researchers want to understand if children with certain pituitary conditions don't make enough oxytocin, which could help guide future treatments.
Boston, MassachusettsAges 7–21 - NCT06886451Recruiting
Preventing vomiting in kids with cancer
This study looks at ways to prevent vomiting in children with cancer who are in the hospital. It aims to help make their treatment experience better.
Toronto, OntarioAges Any age - NCT06448013RecruitingPhase 1
Ziftomenib with chemo for pediatric AML
This trial tests a new drug, ziftomenib, combined with two standard chemotherapies (venetoclax and gemtuzumab) for children and young adults with acute myeloid leukemia (AML) that has come back or not responded to treatment. It looks for specific genetic changes in the leukemia cells.
Houston, TexasAges 3–21 - NCT04107077RecruitingPhase 2
HIPEC surgery plus chemotherapy for advanced stomach cancer
This study tests whether a specialized surgery called HIPEC (heat-treated chemotherapy placed in the belly) can improve outcomes for people with advanced stomach cancer that has reached the lining of the abdomen. It’s given after you’ve already had standard chemotherapy, aiming to better control disease in the belly.
Chicago, IllinoisAges 18 years+ - NCT06191978RecruitingPhase 1
Testing venetoclax with decitabine/cedazuridine for pediatric AML
This trial tests a combination of two oral drugs (venetoclax and decitabine/cedazuridine) for children and teens whose acute myeloid leukemia (AML) has returned or not improved after prior treatment. The goal is to find a safe dose and see if the drugs can help shrink or control the leukemia.
Houston, TexasAges 2–18 - NCT06283251Recruiting
RISE support program for children with cancer
This study tests a program called RISE that helps families with low income manage the financial and emotional challenges of childhood cancer treatment. It aims to see if the program is feasible and helpful for families like yours.
San Francisco, CaliforniaAges Up to 17 years - NCT05019716RecruitingPhase 1/Phase 2
Adding ZEN003694 to chemo for NUT cancer
This early-phase study tests whether adding ZEN003694 to standard chemotherapy (cisplatin/etoposide or carboplatin/paclitaxel) is safe and can help control NUT carcinoma. It enrolls people ages 12–17 and adults, including some patients whose cancer has spread or can’t be safely removed.
Los Angeles, CaliforniaAges 12 years+
Hear when a new Pediatric Cancer Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pediatric cancer patients?
- Yes. Clin2 currently lists 172 recruiting pediatric cancer patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pediatric cancer patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pediatric cancer patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.